Patent Terms Extended Under 35 U.S.C. 156 Certificates extending the terms of the following patents were issued on October 23, 1998. U.S. Patent No. Re. 34,617; Granted May 24, 1994, to Ronald J. Jandacek, et al.; Owner of Record: The Procter and Gamble Company; Title: Vitamized Compositions for Treating Hypocholesterolemia; Classification: 514/23; Product Trade Name: OLEAN (olestra); Original Expiration Date: February 12, 1996; Term Extended: two years; Extended Expiration Date: January 30, 1998. U.S. Patent No. 4,947,840; Granted August 14, 1990, to Ioannis V. Yannas et al.; Owner of Record: Massachusetts Institute of Technology; Title: Biodegradable Templates for the Regeneration of Tissues; Classification: 128/156; Product Trade Name: INTEGRA Artificial Skin; Original Expiration Date: August 21, 2007; Term Extended: 923 days; Extended Expiration Date: March 1, 2010. U.S. Patent No. 5,008,256; Granted April 16, 1991, to John W. Clitherow; Owner of Record: Glaxo Group Limited; Title: Salts for Ranitidine and Complexes of Bismuth with Carboxylic Acids, and Pharmaceutical Compositions Thereof, Classification: 514/184; Product Trade Name: TRITEC (ranitidine bismuth citrate); Original Expiration Date: July 17, 2009; Term Extended: 387 days; Extended Expiration Date: August 8, 2010. U.S. Patent No. 5,019,583; Granted May 28, 1991, to Paul L. Feldman et al.; Owner of Record: Glaxo Wellcome Inc.; Title: N-Phenyl-N-(4-Piperidinyl)Amides Useful as Analgesics; Classification: 514/327; Product Trade Name: ULTIVA Injection (remifentanil hydrochloride); Original Expiration Date: February 15, 2009; Term Extended: 512 days; Extended Expiration Date: July 12, 2010. U.S. Patent No. 5,142,051; Granted August 25, 1992, to Antonin Holy et al.; Owner of Record: Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic and Rega Institut; Title: N-Phosphonylmethoxyalkyl Derivatives of Pyrimidine and Purine Bases and a Therapeutical Composition Therefrom with Antiviral Activity; Classification: 544/243; Product Trade Name: VISTIDE (cidofovir); Original Expiration Date: August 25, 2009; Term Extended: 305 days; Extended Expiration Date: June 26, 2010. Patent Terms Extended Under 35 U.S.C. 156(d)(5) An order extending the term of the following patent was issued on October 23, 1998. U.S. Patent No. 4,291,708; Granted September 29, 1981, to Ephraim H. Frei, et al.; Owner of Record: Yeda Research & Development Co; Title: Apparatus and Method for Detecting Tumors in Tissue: 128/734; Product Trade Name: T-SCAN ; Original Expiration Date: November 2, 1998; Term Extended: one year; Extended Expiration Date: November 2, 1999.